CC
RLAY icon

Corton Capital’s Relay Therapeutics RLAY Stock Holding History

Corton Capital’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,763
Closed -$211K – 599
2024
Q3 		$211K Buy
29,763
+9,133
+44% +$68.2K 0.1% 351
2024
Q2 		$135K Buy
20,630
+2,521
+14% +$17.2K 0.07% 433
2024
Q1 		$150K Sell
18,109
-24,677
-58% -$241K 0.06% 451
2023
Q4 		$471K Buy
42,786
+3,384
+9% +$28.6K 0.15% 185
2023
Q3 		$331K Buy
39,402
+6,727
+21% +$72.3K 0.17% 173
2023
Q2 		$410K Buy
32,675
+19,946
+157% +$248K 0.19% 141
2023
Q1 		$210K Sell
12,729
-548
-4% -$9.83K 0.15% 232
2022
Q4 		$198K Buy
+13,277
New +$254K 0.16% 225

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Corton Capital's RLAY Position: Q4 2024 in Review

Corton Capital sold out of Relay Therapeutics (RLAY) in Q4 2024, closing a stake of 29,763 shares — an estimated $211K sold.

Corton Capital first reported a position in RLAY in Q4 2022 and held it in 8 quarters. The position peaked at $471K in Q4 2023. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

  • Corton Capital reported no remaining Relay Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 29,763 Relay Therapeutics shares in Q4 2024, an estimated $211K.
  • Corton Capital first reported a position in Relay Therapeutics in Q4 2022 and held it in 8 quarters.
  • Corton Capital's Relay Therapeutics position peaked at $471K in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.